4 clinical studies have now been submitted with different authorities for approval, aiming to start soon under the INNODIA framework. For those trials INNODIA will be using the Master-Protocol (https://bit.ly/32jYIGi) established within INNODIA, in collaboration with the Innovative Medicines Initiative (IMI). The start of the trials marks a very important step towards the development of novel treatments to prevent and cure type 1 diabetes.
4 INNODIA trials submitted
25. August 2020